Miller Investment Management’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,986
| Closed | -$49.9K | – | 102 |
|
|
2024
Q3 | $49.9K | Buy |
3,986
+1,986
| +99% | +$24.9K | 0.01% | 102 |
|
|
2024
Q2 | $29.2K | Hold |
2,000
| – | – | ﹤0.01% | 103 |
|
|
2024
Q1 | $44.9K | Hold |
2,000
| – | – | 0.01% | 104 |
|
|
2023
Q4 | $37.8K | Hold |
2,000
| – | – | 0.01% | 101 |
|
|
2023
Q3 | $34.2K | Hold |
2,000
| – | – | 0.01% | 96 |
|
|
2023
Q2 | $60K | Hold |
2,000
| – | – | 0.01% | 95 |
|
|
2023
Q1 | $58.5K | Hold |
2,000
| – | – | 0.01% | 94 |
|
|
2022
Q4 | $39.5K | Hold |
2,000
| – | – | 0.01% | 94 |
|
|
2022
Q3 | $61K | Hold |
2,000
| – | – | 0.01% | 90 |
|
|
2022
Q2 | $46K | Hold |
2,000
| – | – | 0.01% | 90 |
|
|
2022
Q1 | $90K | Hold |
2,000
| – | – | 0.01% | 96 |
|
|
2021
Q4 | $77K | Hold |
2,000
| – | – | 0.01% | 96 |
|
|
2021
Q3 | $102K | Hold |
2,000
| – | – | 0.02% | 89 |
|
|
2021
Q2 | $174K | Hold |
2,000
| – | – | 0.03% | 80 |
|
|
2021
Q1 | $89K | Hold |
2,000
| – | – | 0.02% | 79 |
|
|
2020
Q4 | $51K | Buy |
2,000
+1,000
| +100% | +$25.5K | 0.01% | 77 |
|
|
2020
Q3 | $26K | Buy |
+1,000
| New | +$26K | 0.01% | 69 |
|
|
2019
Q4 | – | Sell |
-800
| Closed | -$15K | – | 79 |
|
|
2019
Q3 | $15K | Buy |
+800
| New | +$15K | ﹤0.01% | 77 |
|
|
2018
Q4 | – | Sell |
-1,600
| Closed | -$68K | – | 76 |
|
|
2018
Q3 | $68K | Hold |
1,600
| – | – | 0.02% | 80 |
|
|
2018
Q2 | $92K | Buy |
+1,600
| New | +$92K | 0.03% | 84 |
|